Starpharma Holdings Ltd (SPL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -125 | -314 | -359 | -625 | -96 |
| Net Acquisitions | N/A | N/A | N/A | 33,281 | N/A |
| Sale Of Investment | N/A | 8 | N/A | N/A | 125 |
| Investing Cash Flow | $-125 | $-306 | $-359 | $32,656 | $29 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 33,915 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,319 |
| Other Financing Activity | -584 | -26 | -26 | -21 | -32 |
| Financing Cash Flow | $-584 | $-26 | $-26 | $-21 | $32,564 |
| Exchange Rate Effect | 288 | 608 | 717 | -464 | 342 |
| Beginning Cash Position | 41,251 | 51,319 | 61,188 | 45,972 | 30,848 |
| End Cash Position | 30,054 | 41,251 | 51,319 | 61,188 | 45,972 |
| Net Cash Flow | $-11,485 | $-10,676 | $-10,586 | $15,680 | $14,782 |
| Free Cash Flow | |||||
| Capital Expenditure | -125 | -314 | -359 | -625 | -97 |
| Free Cash Flow | -125 | -314 | -359 | -625 | -97 |